Skip to main content
Equibles
RXRX $3.24 -5.83%
RXRX logo
RXRX · Recursion Pharmaceuticals, Inc.
Track RXRX — free

Use RXRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RXRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.24 -0.20 (-5.83%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.94B
Shares
535.34M
All earnings calls

Earnings call · FY2023 Q1

Recursion Pharmaceuticals, Inc. (RXRX) Q1 2023 Earnings Call

Concluded May 8, 2023
May 8, 2023 0 turns
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $12.13M +127.5% YoY
Diluted EPS -$0.34
Net income -$65.33M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 8, 2023 10-Q report Filed May 8, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License And Service$12.13M +129% YoY
Grant$0 -100% YoY
Full-screen source Call document

RXRX transcript alerts

Recursion Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →